Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors

World Journal of Gastroenterology

Volumn 15, Issue 3, 2009, Pages 289-299

  Leen, Edward ^a   Kumar, Senthil ^a   Khan, Shahid A ^a   Low, Gavin ^a   Ong, Keh Oon ^a   Tait, Paul ^a   Averkiou, Mike ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

Contrast enhanced 3D ultrasound; Liver tumors; Radiofrequency ablation

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FOLLOW UP; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MINIMALLY INVASIVE SURGERY; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION;

EID: 59249093941     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.289     Document Type: Article

References (32)

1. O'Brien MJ. Cancer of the colon and rectum: current concepts of aetiology and pathogenesis. Ir J Med Sci 1988; 157: 5-15
2. McArdle CS, Hole D, Hansell D, Blumgart LH, Wood CB. Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg 1990; 77: 280-282
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71
4. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-946
5. Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, Majno P, Engerran L. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225: 51-60; discussion 60-62
6. Fernández-Trigo V, Shamsa F, Sugarbaker PH. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 1995; 117: 296-304
7. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160: 3227-3230
8. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
9. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
10. d'Arsonval MA. Action physiologique des courants alternatifs. CR Soc Biol 1891; 43: 283-286
11. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156
12. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005; 23: 1358-1364
13. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003; 10: 338-347
14. Goldberg SN, Gazelle GS, Solbiati L, Livraghi T, Tanabe KK, Hahn PF, Mueller PR. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998; 170: 1023-1028
15. Lencioni R, Goletti O, Armillotta N, Paolicchi A, Moretti M, Cioni D, Donati F, Cicorelli A, Ricci S, Carrai M, Conte PF, Cavina E, Bartolozzi C. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8: 1205-1211
16. Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229-237
17. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH, Jarnagin WR. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-1044
18. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072
19. Moug SJ, Leen E, Horgan PG, Imrie CW. Radiofrequency ablation has a valuable therapeutic role in metastatic VIPoma. Pancreatology 2006; 6: 155-159
20. Conlon R, Jacobs M, Dasgupta D, Lodge JP. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003; 16: 211-216
21. Jarnagin WR, Bach AM, Winston CB, Hann LE, Heffernan N, Loumeau T, DeMatteo RP, Fong Y, Blumgart LH. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 2001; 192: 577-583
22. Cervone A, Sardi A, Conaway GL. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 2000; 66: 611-615
23. Charnley RM, Morris DL, Dennison AR, Amar SS, Hardcastle JD. Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg 1991; 78: 45-48
24. Leen E, Horgan P. Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr Probl Diagn Radiol 2003; 32: 66-87
25. Wilson SR, Burns PN. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging. Semin Liver Dis 2001; 21: 147-159
26. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, Claudon M, Calliada F, Correas JM, LaFortune M, Campani R, Hoffmann CW, Cosgrove DO, LeFevre F. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361-370
27. Leen E, Ceccotti P, Moug SJ, Glen P, MacQuarrie J, Angerson WJ, Albrecht T, Hohmann J, Oldenburg A, Ritz JP, Horgan PG. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006; 243: 236-240
28. Leen E, Moug S, Logue J, Darrien J, Angerson WJ, Horgan P. Value of contrast enhanced ultrasound (CE-US) in the radiofrequency ablation (RFA) of focal liver tumours: is it needed? Radiology 2005: Supplement 2005
29. Bricault I, Kikinis R, Morrison PR, Vansonnenberg E, Tuncali K, Silverman SG. Liver metastases: 3D shape-based analysis of CT scans for detection of local recurrence after radiofrequency ablation. Radiology 2006; 241: 243-250
30. Downey DB, Fenster A, Williams JC. Clinical utility of three-dimensional US. Radiographics 2000; 20: 559-571
31. Xu HX, Yin XY, Lu MD, Xie XY, Xu ZF, Liu GJ. Usefulness of three-dimensional sonography in procedures of ablation for liver cancers: initial experience. J Ultrasound Med 2003; 22: 1239-1247
32. Rose SC, Hassanein TI, Easter DW, Gamagami RA, Bouvet M, Pretorius DH, Nelson TR, Kinney TB, James GM. Value of three-dimensional US for optimizing guidance for ablating focal liver tumors. J Vasc Interv Radiol 2001; 12: 507-515